# A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

> **NCT03311932** · PHASE1 · COMPLETED · sponsor: **Neurocrine UK Limited** · enrollment: 51 (actual)

## Conditions studied

- Adrenal Insufficiency

## Interventions

- **DRUG:** Infacort®
- **DRUG:** Cortef®

## Key facts

- **NCT ID:** NCT03311932
- **Lead sponsor:** Neurocrine UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-16
- **Primary completion:** 2018-07-13
- **Final completion:** 2018-07-13
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-10-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03311932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03311932, "A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03311932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*